Animal study suggests utility of PET for Menkes disease

03/26/2014 | (free registration)

Japanese researchers used PET with copper-64 to track and visualize the effects of treatment for Menkes disease, a rare condition in which patients are unable to absorb copper. After researchers injected mouse models with the isotope along with either disulfiram or D-penicillamine, PET showed higher copper uptake in the brain and reduced uptake in the kidneys in the disulfiram group compared with those treated with copper alone. The results published in the Journal of Nuclear Medicine suggest the efficacy of the drug in increasing copper uptake in the brain and the potential of PET for guiding development of Menkes disease treatment.

View Full Article in: (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA